MoneyWorks4Me

AMI Organics informs about execution of supply agreement

15 Sep 2023 Evaluate

In accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, AMI Organics has informed that the company has entered into Supply Agreement on September 14, 2023 with Fermion, subsidiary of Orion Corporation, Finland, for supply of an advance pharmaceutical intermediates product. The details with respect to the order, as required under Regulation 30 of the SEBI LODR read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023, are enclosed as Annexure-A. The above information is also being made available on the website of the Company at www.amiorgnics.com.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..